RWM
RDY icon

Reston Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Reston Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,025
Closed -$16.3K – 341
2024
Q3 		$16.3K Buy
+1,025
New +$16.5K 0.01% 206

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Reston Wealth Management's RDY Position: Q4 2024 in Review

Reston Wealth Management sold out of Dr. Reddy's Laboratories (RDY) in Q4 2024, closing a stake of 1,025 shares — an estimated $16.3K sold.

Reston Wealth Management first reported a position in RDY in Q3 2024 and held it in 1 quarter. The position peaked at $16.3K in Q3 2024. 246 funds tracked by Wall St. Rank hold RDY as of Q4 2024.

  • Reston Wealth Management reported no remaining Dr. Reddy's Laboratories position as of Q4 2024 after selling out during the quarter.
  • Reston Wealth Management sold 1,025 Dr. Reddy's Laboratories shares in Q4 2024, an estimated $16.3K.
  • Reston Wealth Management first reported a position in Dr. Reddy's Laboratories in Q3 2024 and held it in 1 quarter.
  • Reston Wealth Management's Dr. Reddy's Laboratories position peaked at $16.3K in Q3 2024.
  • 246 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2024.

Based on Reston Wealth Management's 13F filing for Q4 2024, filed 23 Jan 2025.